Topical nasal therapy of allergic rhinitis - An analysis of efficacy and costs;Die topische intranasale therapie der allergischen rhinitis: Eine wirksamkeits- und kostenanalyse

Allergologie

Volumn 26, Issue 5, 2003, Pages 177-195

  Lange, B ^a   Bachert, C ^b  

^a Institut fur Atemwegsforschung GmbH   (Germany)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Allergic rhinitis; Cost effectiveness; Efficacy; Metaanalysis; Nasal antihistamines; Nasal chromones; Nasal glucocorticosteroids

Indexed keywords

ANTIHISTAMINIC AGENT; AZELASTINE; BECLOMETASONE DIPROPIONATE; BETAMETHASONE; BUDESONIDE; CHROMONE DERIVATIVE; CROMOGLYCATE DISODIUM; DEXAMETHASONE; FLUNISOLIDE; FLUOCORTIN; FLUTICASONE PROPIONATE; GLUCOCORTICOID; LEVOCABASTINE; MOMETASONE FUROATE; NEDOCROMIL; STEROID; TRIAMCINOLONE ACETONIDE;

ALLERGIC RHINITIS; ARTICLE; ATOPY; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG EFFICACY; GERMANY; HUMAN; META ANALYSIS; PRACTICE GUIDELINE;

EID: 0038171318     PISSN: 03445062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (124)

1. Bachert C., B. Lange: Allergische Rhinitis und Asthma. Allergologie 23, 292-301 (2000).
2. Juniper E.F.: Rhinitis management: the patient's perspective. Clin. Exp. Allergy 28 (Suppl. 6), 34-38 (1998).
3. van Cauwenberge P., C. Bachert, G. Passalacqua, J. Bousquet, G.W. Canonica, S.R. Durham, WJ Fokkens, P.H. Howarth, V. Lund, H.-J. Malling, N. Mygind, D. Passali, G.K. Scadding, D.-Y. Wang: EAACI Position Paper: Consensus statement on the treatment of allergic rhinitis. Allergy 55, 116-134 (2000).
4. Bousquet and the ARIA Workshop Group: Allergic rhinitis and its impact on asthma. ARIA Workshop Report in collaboration with the World Health Organization. J. Allergy Clin. Immunol. 108, S147-S333 (2001).
5. Bachert C.: Konsensus-Arbeitsgruppe. Die nasale Hyperreaktivität - die allergische Rhinitis und ihre Differentialdiagnosen. Allergologie 20, 39-52 (1997).
6. Stempel D.A., M. Thomas: Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticoids versus nonsedating antihistamines. Am. J. Man. Care 4, 89-96 (1998).
7. 1 receptor antagonists in allergic rhinitis: systematic review of randomized controlled trials. Br. Med. J. 317, 1624-1629 (1998).
8. Stempel D.A., R. Woolf: The cost of treating allergic rhinitis. Curr. Allergy Asthma Rep. 2, 223-230 (2002).
9. Bachert C., M. Wagenmann, S. Vossen-Holzenkamp: Intranasal levocabastine provides fast and effective protection from nasal allergen challenge. Rhinology 34, 140-143 (1996).
10. Meltzer E.O., K.A. Rickard, R.E. Westlund, C.K. Cook: Onset of therapeutic effect of fluticasone propionate aqueous nasal spray. Ann. Allergy Asthma Immunol. 86, 286-291 (2001).
11. Chervinsky P.: Clinical review of once-daily beclometasone dipropionate for seasonal allergic rhinitis. Clin. Ther. 18, 790-796 (1996).
12. Edwards T.B.: Effectiveness and safety of beclomethasone dipropionate, an intranasal corticosteroid, in the treatment of patients with allergic rhinitis. Clin. Ther. 17, 1032-1041 (1995).
13. Brogden R.N., D. McTavish: Budesonide. An updated review of its pharmacological properties and therapeutic efficacy in asthma and rhinitis. Drugs 44, 375-407 (1992).
14. Wiseman L.R., P. Benfield: Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis. Drugs 53, 885-907 (1997).
15. Dibildox J.: Safety and efficacy of momethasone furoate aqueous nasal spray in children with allergic rhinitis: results of recent clinical trials. J. Allergy Clin. Immunol. 108, S54-S58 (2001).
16. Onrust S.V., H.M. Lamb: Momethasone furoate. A review of its intranasal use in allergic rhinitis. Drugs 56, 725-745 (1998).
17. Davies R.J., H.S. Nelson: Once daily momethasone furoate nasal spray: efficacy and safety of a new nasal glucocorticoid for allergic rhinitis. Clin. Ther. 19, 27-38 (1997).
18. Gawchik S.M., C.L. Saccar: Arisk-benefit assessment of intranasal triamcinolone acetonide in allergic rhinitis. Drug Saf. 23, 309-322 (2000).
19. Jeal W., D. Faulds: Triamcinolone acetonide. A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis. Drugs 53, 257-280 (1997)
20. Lieberman P.: Management of allergic rhinitis with a combination antihistamine/antiinflammatory agent. J. Allergy Clin. Immunol. 103, S400-S404 (1999).
21. McNeely W., L.R. Wiseman. Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis. Drugs 56, 91-114 (1998).
22. Schuermans V., P.J. Lewi, L.M. Gypen, H. Goy-vaerts, G. Vanden Bussche: Meta-analysis of the global evaluation of levocabastine nasal spray versus placebo. Drug Inf. J. 27, 575-584 (1993).
23. Bahmer F.A.: Topical levocabastine - an effective alternative to oral antihistamines in seasonal allergic rhinoconjunctivitis. Clin. Exp. Allergy 25, 220-227 (1995).
24. Noble S., D. McTavish: Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis. Drugs 50, 1032-1049 (1995).
25. Ratner P.H., P.M. Ehrlich, S.M. Fineman, E.O. Meltzer, D.P. Skoner: Use of intranasal cromolyn sodium for allergic rhinitis. Mayo Clin. Proc. 77, 350-354 (2002).
26. Knottnerus LG, PA. Riley: A clinical overview of Tilarin. Allergy 51 (Suppl. 28), 28-34 (1996).
27. Mabry R.L.: Topical pharmacotherapy for allergic rhinitis: nedocromil. Am. J. Otolaryngol. 14, 379-381 (1993).
28. Review Manager (Revman): Computer Program. (Version 4.1 for Windows.). Update Software. Oxford, England, http://www.cochrane.de/cochrane/revman.htm 2000.
29. FDA/Center for Drug Evaluation and Research: Guidance for industry. Allergic rhinitis: development programs for drug products. http://www.fda. gov/cder/guidance/2718dft.htm 2000.
30. Sutton A.J., K.R. Abrams, D.R. Jones, T.A. Sheldon, F. Song: Methods for meta-analysis in medical research (1st ed.). John Wiley and Sons, Chichester 2000.
31. Song F., N. Freemantle, T.A. Sheldon, A. House, P. Watson, A. Long: Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. Br. Med. J. 306, 683-687 (1993).
32. Gleser L.J., I. Olkin: Stochastically dependent effect sizes. In: Cooper H., L.V. Hedges: The Handbook of Research Synthesis. Russell Sage-Foundation, New York 1994, 339-355.
33. 1 antagonist, in seasonal allergic rhino-conjunctivitis. Allergy 42, 512-515 (1987).
34. Berlin J.M., S.J. Golden, S. Teets, E.B. Lehman, T. Lucas, T.J. Craig: Efficacy of a steroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis. J. Am. Osteopath. Ass. 100, S8-S13 (2000).
35. Davies R.J., V.J. Lund, V.J. Harten-Ash: The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis. Rhinology 31, 159-164 (1993).
36. Di Lorenzo G., F. Gervasi, A. Drago, M. Esposito, M. Pelleteri, A. Di Salvo, D. Cosentino, M. Potestio, A. Colombo, G. Candore, S. Mansueto, C. Caruso: Comparison of the effects of fluticasone propionate aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics. Clin. Exp. Allergy 29, 1367-1377 (1999).
37. Dorow P., R. Aurich, U. Petzold: Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide. Arzneimittelforschung Drug Res. 43, 909-912 (1993).
38. Gastpar H., R. Aurich, U. Petzold, P. Dorow, H. Enzmann, R. Gering, H.P. Köcky, A. Philipp, W. Renz: Intranasal treatment of perennial allergic rhinitis. Comparison of azelastine nasal spray and budesonide nasal aerosol. Arzneimittelforschung Drug Res. 43, 475-479 (1993).
39. Newson-Smith G., M. Powell, M. Baehre, S.P. Garnham, M.T. MacMahon: A placebo-controlled study comparing the efficacy of intranasal azel-astine and beclomethasone in the treatment of seasonal allergic rhinitis. Eur. Arch. Otorhinolaryngol. 54, 236-241 (1997).
40. Ortolani C., A. Foresi, G. Di Lorenzo, G. Bagnato, F. Bonifazi, N. Crimi, L. Emmi, M. Prandini, G.E. Senna, A. Tursi, C. Mirone, C. Leone, P. Fina, R. Testi and the FLNCO Italian Study Group. A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. Allergy 54, 1173-1180 (1999).
41. Pelucchi A., A. Chiapparino, B. Mastropasqua, L. Marazzini, A. Hernandez, A. Foresi: Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to metacholine in allergic rhinitis in response to grass pollens. J. Allergy Clin. Immunol. 95, 515-523 (1995).
42. Stern M.A., A.G. Wade, S.M. Ridout, L.M. Cambel: Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine. Ann. Allergy Asthma Immunol. 81, 354-358 (1998).
43. Svensson C., M. Andersson, L. Greiff, L.-O. Blychert, C.G.A. Persson: Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis. Allergy 53, 367-374 (1998).
44. Wang D., J. Smitz, M. De Waele, P. Clement: Effect of topical applications of budesonide and azelastine on nasal symptoms, eosinophil count and mediator release in atop ic patients after nasal allergen challenge during the pollen season. Int. Arch. Allergy Immunol. 114, 185-192 (1997).
45. Bjerrum P., P. Illum: Treatment of seasonal allergic rhinitis with budesonide and disodium cromoglycate. Allergy 40, 65-69 (1985).
46. Bousquet J., I. Chanal, M.C. Alquié, D. Charpin, A. Didier, J. Germouty, P. Greillier, H.M. Ickivic, Y. Maria, F. Montané, M. Perrin-Fayolle, C. Seignalet, J.C. Severac, A. Vergnenègre, B. Aubert, J. Bons: Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study. Allergy 48, 327-333 (1993).
47. Fisher W.G.: Comparison of budesonide and disodium cromoglycate for the treatment of seasonal allergic rhinitis in children. Ann. Allergy 73, 515-520 (1994).
48. Frankland A.W., S.R. Walker: A comparison of intranasal betamethasone valerate and sodium cromoglycate in seasonal allergic rhinitis. Clin. Allergy 5, 295-300 (1975).
49. Haahtela T.: Comparisons among HC 20-511 (ketotifen), clemastine, DSCG and beclomethasone dipropionate in nasal challenge. Ann. Allergy 41, 345-347 (1978).
50. Kellerman D.J., E.O. Meltzer, F.C. Hampel, P. Chervinsky, L.E. East, K.D. Dunn, L.M. Petty: Superiority of beclomethasone over cromolyn in the self-treatment of seasonal allergic rhinitis (abstract 174). Pharmacotherapy 18, 1165 (1998).
51. Morrow-Brown H., F.A. Jackson, G.M. Pover: A comparison of beclomethasone dipropionate aqueous nasal spray and sodium cromoglycate nasal spray in the management of seasonal allergic rhinitis. Allergol. Immunopathol. 12, 355-361 (1984).
52. Pelikan Z.: The effects of disodium cromoglycate (DSCG) and beclomethasone dipropionate (BDP) on the delayed nasal mucosa response to allergen challenge. Ann. Allergy 52, 111-124 (1984).
53. Sensi L.G., A. Seri, A. Siracusa, L. Pertici, F. Marucci: Allergic rhinitis in children: effects of flunisolide and disodium cromoglycate on nasal eosinophil cationic protein. Clin. Exp. Allergy 27, 270-276 (1997).
54. Welsh P.W., W.E. Stricker, C.-P., Chu, J.M. Naessens, M.E. Reese, C.E. Reed, J.P. Marcoux: Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin. Proc. 62, 125-134 (1987).
55. Wilson J.A., S.R. Walker: A clinical study of the prophylactic use of betamethasone valerate and sodium cromoglycate in the treatment of seasonal allergic rhinits. J. Laryngol. Otol. 90, 201-206 (1976).
56. Cruz M.A., N. Aguila: Levocabastina vs. cromoglicato de sodio en el tratamiento de la rinitis alérgica estacional. Inv. Med. Int. 20, 187-192 (1993).
57. 1 receptor antagonist, and disodium cromoglycate in a nasal provocation test with allergen. Br. J. Pharmacol. 22, 389-394 (1986).
58. Kremer B., A. Tündermann, O. Goldschmidt and members of the Deutsche Rhinitis Studiengruppe: Onset of action, effectiveness and tolerance of levocabastine and nedocromil in topical therapy of seasonal allergic rhinoconjunctivitis. Arzneimittelforschung Drug Res. 48, 924-930 (1998).
59. Palma-Carlos A.G., C. Chieira, T.A. Conde, J.A. Robalo Cordeiro: Double-blind comparison of levocabastine nasal spray with sodium cromoglycate nasal spray in the treatment of seasonal allergic rhinitis. Ann. Allergy 67, 394-398 (1991).
60. Schata M., W. Jorde, U., Richartz-Barthauer: Levocabastine nasal spray better than sodium cromoglycate and placebo in the topical treatment of seasonal allergic rhinitis. J. Allergy Clin. Immunol. 87, 873-878 (1991).
61. Vermeulen J., M. Mercer: Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children. Pediatr. Allergy Immunol. 5, 209-213 (1994).
62. Banov C.H., W.S. Silvers, A.W. Green, J.H. van Bavel, J.A. Winder, G. Feiss, B. Simpson, J.A. Furst, J.A. Smith: Placebo-controlled, double-blind study of the efficacy and safety of triamcinolone acetonide aerosol nasal inhaler in pediatric patients with seasonal allergic rhinitis. Clin. Ther. 18, 265-272 (1996).
63. Bende M., T. Carrillo, I. Vóna, M. da Graca Castel-Branco, L. Arheden: A randomized comparison of the effects of budesonide and momethasone furoate aqeous nasal sprays on peak flow rate and symptoms in perennial allergic rhinitis. Ann. Allergy Asthma Immunol. 88, 617-623 (2002).
64. Bronsky E.A., D.W. Aaronson, R.B. Berkowitz, P. Chervinsky, D. Graft, H.B. Kaiser, B. Moss, R.A. Nathan, D.S. Pearlman, PH. Ratner, J.M. Adelglass, D.L. Southern, J. van Bavel, F. Hampel, W.E. Stricker, J.A. Fourré, K.B. Nolop: Dose ranging study of momethasone furoate (Nasonex) in seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 79, 51-56 (1997).
65. Findlay S., F. Huber, J. Garcia, L. Huang: Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitis. Ann. Allergy 68, 228-232 (1992).
66. Graft D., D. Aaronson, P. Chervinsky, J. Melamed, A. Pedinoff, J.P. Rosen, E.J. Schenkel, M.L. Vandewalker, A. Keim, P.K. Jensen, K. Nolop, B. Mesarina-Wicki: A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with momethasone furoate nasal spray. J. Allergy Clin. Immunol. 98, 724-731 (1996).
67. Hebert J.R., K. Nolop, B.N. Lutsky: Once-daily momethasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: an active-and placebo-controlled study. Allergy 51, 569-576 (1996).
68. Kobayashi R.H., W.N. Beaucher, J.W. Koepke, A. Luskin, J.H. Ransom, J.P. Rosen, M.J. Sullivan, V.B. Alderfer, B. Simpson, J.A. Smith: Triamcinolone acetonide aqueous nasal spray for the treatment of patients with perennial allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled study. Clin. Ther. 17, 503-513 (1995).
69. Meltzer E.O., A.A. Jalowayski, H.A. Orgel, A.G. Harris: Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with momethasone furoate nasal spray. J. Allergy Clin. Immunol. 102, 39-49 (1998).
70. Meltzer E.O., W.E. Berger, R.B. Berkowitz, D.J. Dvorin, A.F. Finn, S.P. Galant, J. Grossman, F.C. Hampel, P.H. Ratner, M.E. Ruff, E.J. Schenkel, A.T. Segal, N. Segall, G.E. Stewart II, I. Tripathy, D.P. Skoner, R. Anolik, R.J. Dockhorn, J. van Bavel, B. Mesarina-Wicki, K.B. Nolop: A dose-ranging study of momethasone furoate aqueous nasal spray in children with seasonal allergic rhinitis. J. Allergy Clin. Immunol. 104, 107-114 (1999).
71. Munk Z.M., C. LaForce, J.A. Furst, B. Simpson, G. Feiss, J. Smith: Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 77, 277-281 (1996).
72. Munk Z.M., G.N. Gross, F.C. Hampel, P.H. Ratner: Preseasonal, once daily triamcinolone acetonide nasal aerosol for seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 78, 325-331 (1997).
73. Rosenthal R., W. Berger, E. Bronsky, R. Dockhorn, P. Korenblat, K. Lampl, W. Lumry, S. Pollard, G. Raphael, C. Rohr, G. Shapiro, M. Valentine, A. Wanderer, L. Fleming, N. La Vallee, M. Stepanians, J. Karafilidis, J. Shilstone, E. Ellis: Tri-nasal triamcinolone acetonide nasal spray 200 and 400 μg qd versus placebo and Nasacort triamcinolone acetonide nasal aerosol 440 μg qd in patients suffering from seasonal allergic rhinitis during the grass season. Am J. Rhinol. 12, 427-433 (1998).
74. Settipane G., P.E. Korenblat, J. Winder, W. Lumry, J. Murphree, V. Alderfer, B. Simpson, J.A. Smith: Triamcinolone acetonide aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: a placebo-controlled, double-blind study. Clin. Ther. 17, 252-263 (1995).
75. Spector S., E. Bronsky, P. Chervinsky, G. Lotner, J. Koepke, J. Selner, D. Pearlman, D. Tinkelman, S. Weakley, V. Alderfer, J.W. Gorder, D.J. Wilkinson: Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis. Ann. Allergy 64, 300-305 (1990).
76. Storms W., E. Bronsky, S. Findlay, D. Pearlman, S. Rosenberg, G. Shapiro, L. Southern, D. Tinkelman, S. Weakley, M. Welch, H. Zeitz, D. Wilkinson, S. McMahon, J. Garcia: Once daily triamcinolone acetonide nasal spray is effective for the treatment of perennial allergic rhinitis. Ann. Allergy 66, 329-334 (1991).
77. Storms W.W., D.L. Southern, G. Feiss, B. Simpson, J.A. Furst, J.A. Smith: Efficacy of triamcinolone acetonide aerosol nasal inhaler in children with perennial allergic rhinitis. Pediatr. Asthma Allergy Immunol. 10, 59-64 (1996).
78. Tinkelman D., C. Falliers, G. Gross, A. Segal, L. Southern, M. Welch, H. Yeates, J. Gorder, J. Garcia: Multicenter evaluation of triamcinolone acetonide nasal aerosol in the treatment of adult patients with seasonal allergic rhinitis. Ann. Allergy 64, 234-240 (1990).
79. Welch M.J., E.A. Bronsky, J. Grossman, G.G. Shapiro, D.G. Tinkelman, J.D. Garcia, M.S. Gillen: Clinical evaluation of triamcinolone acetonide nasal aerosol in children with perennial allergic rhinitis. Ann. Allergy 67, 493-498 (1991).
80. Wilson A.M., L.C. Orr, E.J. Sims, B.J. Lipworth: Effects of monotherapy with intranasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin. Exp. Allergy 31, 61-68 (2001).
81. Ciprandi G., V. Ricca, G. Passalacqua, T. Truffelli, C. Bertolini, N. Fiorino, A.M. Riccio, M. Bagnasco, G.W. Canonica: Seasonal rhinitis and azelastine: long- or short-term treatment? J. Allergy Clin. Immunol. 99, 301-307 (1997).
82. Dahl R., B. Pedersen, B. Larsen: Intranasal levocabastine for the treatment of seasonal allergic rhinitis: a multicentre, double-blind, placebo-controlled trial. Rhinology 33, 121-125 (1995).
83. Golden S., S.J. Teets, E.B. Lehman, E.A. Mauger, V. Chinchilli, J.M. Berlin, S. Kakumanu, T. Lucus, T.J. Craig: Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Ann. Allergy Asthma Immunol. 85, 53-57 (2000).
84. Hampel Jr. F.C., B.G. Martin, S. Travers, K. Karcher, D. Holton: Efficacy and safety of levocabastine nasal spray for seasonal allergic rhinitis. Am. J. Rhinol. 13, 55-62 (1998).
85. Herman D., R. Garay, M. Le Gal: A randomized double-blind placebo-controlled study of azelastine nasal spray in children with perennial rhinitis. Int. J. Pediatr. Otorhinolaryngol. 39, 1-8 (1997).
86. LaForce C., R.J. Dockhorn, B.M. Prenner, T.J. Chu, M.J. Kraemer, M.D. Widlitz, T.A. D'Eletto, J.F. Freitag: Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial. Ann. Allergy Asthma Immunol. 76, 181-188 (1996).
87. Ratner P.H., S.R. Findlay, F.C. Hampel Jr., J. van Bavel, M.D. Widlitz, J.J. Freitag: A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis. J. Allergy Clin. Immunol, 94, 818-825 (1994).
88. Storms W.W., D.S. Pearlman, P. Chervinsky, J. Grossman, P.C. Halverson, J.J. Freitag, M.D. Widlitz: Effectiveness of azelastine nasal solution in seasonal allergic rhinitis. ENT J. 73, 382-394 (1994).
89. Althaus M.A., W.J. Pichler: Nasal application of a gel formulation of N-acetyl-aspartyl glutamic acid (NAAGA) compared with placebo and disodium cromoglycate in the symptomatic treatment of pollinosis. Allergy 49, 188 (1994).
90. Bellioni P., F. Salvinelli, F. Patalano, F. Ruggieri: A double-blind group comparative study of nedocromil sodium in the treatment of seasonal allergic rhinitis. Rhinology 26, 281-287 (1988).
91. Blair H., R.L. Herbert: Treatment of seasonal allergic rhinitis with 2% sodium cromoglycate (BP) solution. Clin. Allergy 3, 283-288 (1973).
92. Chandra R.K., G. Heresi, G. Woodford: Double-blind controlled cross-over trial of 4% intranasal sodium cromoglycate solution in patients with seasonal allergic rhinitis. Ann. Allergy 49, 131-134 (1982).
93. Coffman D.A.: A controlled trial of disodium cromoglycate in seasonal allergic rhinitis. Br. J. Clin. Pract. 25, 403-406 (1971).
94. Cohan R.H., F.L. Bloom, R.B. Rhoades, H.J. Wittig, L.D. Haugh: Treatment of perennial allergic rhinitis with cromolyn sodium. Double-blind study on 34 adult patients. J. Allergy Clin. Immunol 58, 121-128 (1976).
95. Craig S., E. Rubinstein, R.E. Reisman, C.E. Arbesman: Treatment of ragweed hay fever with intranasally administered disodium cromoglycate. Clin. Allergy 7, 569-576 (1977).
96. Donnelly A., D. Bernstein, S. Goldstein, J. Grossman, H.J. Schwartz, T.B. Casale: Speed of onset of action of Tilarin. Allergy 51 (Suppl. 28), 14-19 (1996).
97. Druce H.M., S. Goldstein, J. Melamed, J. Grossman, B.A. Moss, R.G. Townley: Multicenter placebo-controlled study of nedocromil sodium 1% nasal solution in ragweed seasonal allergic rhinitis. Ann. Allergy 65, 212-216 (1990).
98. Frostad A.B.: The treatment of seasonal allergic rhinitis with a 2% aqueous solution of sodium cromoglycate delivered by a metered dose nasal spray. Clin. Allergy 7, 347-353 (1977).
99. Holopainen E., A. Backman, O.P. Salo: Effect of disodium cromoglycate on seasonal allergic rhinitis. Lancet 1, 55-57 (1971).
100. Knight A., D.J. Underdown, F. Demanuele, F.E. Hargreave: Disodium cromoglycate in ragweed-allergic rhinitis. J. Allergy Clin. Immunol. 58, 278-283 (1976).
101. McDowell M., E. Spitz: Treatment of chronic perennial allergic rhinitis: a double-blind trial of cromolyn sodium. Ann. Allergy 39, 169-174 (1977).
102. Meltzer E.O. for the NasaCrom Study Group: Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: a placebo-controlled study. Clin. Ther. 24, 942-952 (2002).
103. Nizami R.M., M.T. Baboo: Efficacy, double-blind, crossover study of sodium cromoglycate in patients with seasonal allergic rhinitis. Ann. Allergy 38, 42-45 (1977).
104. Posey W.C., H.S. Nelson: Controlled trials with four per cent cromolyn spray in seasonal allergic rhinitis. Clin. Allergy 7, 485-496 (1977).
105. Ruhno J., J. Denburg, J. Dolovich: Intranasal nedocromil sodium in the treatment of ragweed-allergic rhinitis. J. Allergy Clin. Immunol. 81, 570-574 (1988).
106. Schuller D.E., J.E. Selcow, T.H. Joos, P.J. Hannaway, S.R. Hirsch, H.J. Schwartz, W.V. Filley, J.N. Fink: A multicenter trial of nedocromil sodium, 1% nasal solution, compared with cromolyn sodium and placebo in ragweed seasonal allergic rhinitis. J. Allergy Clin. Immunol. 86, 554-561 (1990).
107. Schwartz H.J., L.D. Ellis, T.H. Sher: The efficacy and safety of nedocromil sodium 1% nasal solution in the treatment of ragweed seasonal allergic rhinitis. Am. J. Rhinol. 5, 241-247 (1991).
108. Sipilä P., M. Sorri, J. Pukander: Double-blind comparison of nedocromil sodium (1% nasal spray) and placebo in rhinitis caused by birch pollen. Clin. Otolaryngol. 12, 365-370 (1987).
109. Warland A., B. Kapstad: The effect of disodium cromoglycate in perennial allergic rhinitis. A controlled clinical study. Acta Allergol. 32, 195-199 (1977).
110. Welsh P.W., J.M. Yunginger, E.B. Kern, G.J. Gleich: Preseasonal IgE ragweed antibody level as a predictor of response to therapy of ragweed hay fever with intranasal cromolyn sodium solution. J. Allergy Clin. Immunol. 60, 104-109 (1977).
111. Bucher H.C., G.H. Guyatt, L.E. Griffith, S.D. Walter: The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J. Clin. Epidemiol. 50, 683-691 (1997).
112. Rote Liste: ECV Editio Cantor, Aulendorf 2002.
113. Minshall E., O. Ghaffar, L. Cameron, F. O'Brien, H. Quinn, J. Rowe-Jones, R.J. Davies, A. Prior, V.J. Lund, I.S. Mackay, K. Nolop, B. Lutsky, S.R. Durham, Q. Hamid: Assessment by nasal biopsy of long-term use of momethasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol. Head Neck Surg. 118, 648-654 (1998).
114. Passalacqua G., M. Albano, G.W. Canonica, C. Bachert, P. van Cauwenberge, R.J. Davies, S.R. Durham, K. Kontou-Fili, F. Horak, H.J. Malling: Inhaled and nasal corticosteroids: safety aspects. EAACI Position Paper. Allergy 55, 16-33 (2000).
115. Allen D.B.: Systemic effects of intranasal steroids: an endocrinologist's perspective. J. Allergy Clin. Immunol. 106, S179-S190 (2000).
116. Bachert C., K.F. Lukat, B. Lange: Short-term use of intranasal corticosteroids: lack of systemic effects. J. Allergy Clin. Immunol. 109, 573-574 (2002).
117. 1 receptor antagonists. An EAACI Position Paper. Allergy 51, 666-675 (1996).
118. van Cauwenberge P., V. Lund, J. Bousquet, T. El Akkad: Profiles and symptom severity of patients presenting to general practice with seasonal allergic rhinitis (abstract 696). Allergy 55 (Suppl. 63), 197 (2000).
119. Nash D.B., S.D. Sullivan, J. Mackowiak: Optimizing quality of care and cost effectiveness in treating allergic rhinitis in a managed care setting. Am. J. Manag. Care 6 (Suppl.), S3-S15 (2000).
120. Das Management der Allergischen Rhinitis und ihr Einfluss auf das Asthma: Ein Leitfaden für Ärzte und Fachpersonal auf Grundlage des Workshop-Berichts "Allergic Rhinitis and its Impact on Asthma" in Zusammenarbeit mit der Weltgesundheitsorganisation (WHO). Übersetzung ins Deutsche durch C. Bachert und B. Lange. Allergologie 25, 7-18 (2000).
121. Vermeire P.A., K.F. Rabe, J.B. Soriano, W.C. Maier: Asthma control and differences in management practices across seven European countries. Respir. Med. 96, 142-149 (2002).
122. Ables A.Z., M.T. Godenick, S.R. Lipsitz: Improving family practice residents' compliance with asthma practice guidelines. Fam. Med. 34, 23-28 (2002).
123. Taylor D.M., T.E. Auble, W.J. Calhoun, V.N. Mosesso: Current outpatient management of asthma shows poor compliance with International Consensus Guidelines. Chest 116, 1638-1645 (1999).
124. Jans M.P., F.G. Schellevis, W. van Hensbergen, T. Dukkers van Emden, J.T. van Eijk: Management of asthma and COPD patients: feasibility of the application of guidelines in general practice. Int. J. Qual. Health Care 10, 27-34 (1998).